|1.||Jaskowiak, Nora T: 1 article (09/2005)|
|2.||Posner, Mitchell C: 1 article (09/2005)|
|3.||Mehta, Neil: 1 article (09/2005)|
|4.||Wardak, Abdullah: 1 article (09/2005)|
|5.||Lopez, Carlos A: 1 article (09/2005)|
|6.||Salloum, Rabih M: 1 article (09/2005)|
|7.||Ohno, Tsuneya: 1 article (09/2005)|
|8.||Beckett, Michael A: 1 article (09/2005)|
|9.||Mauceri, Helena J: 1 article (09/2005)|
|10.||Weichselbaum, Ralph R: 1 article (09/2005)|
|2.||Respiratory Tract Infections (Respiratory Tract Infection)
04/01/1986 - "When combined with surgical resection of primary tumors, forphenicinol administration both before and after resection suppressed the growth of recurrent tumors and prolonged the survival period of the mice."
11/01/1983 - "An optimal dose of forphenicinol for cancer patients was considered to be in a range of 10-100 mg/day."
08/01/1982 - "The antitumor activities of forphenicinol against murine transplantable tumors were examined. "
08/01/1986 - "A high performance liquid chromatographic method is described for monitoring forphenicinol, a possible therapeutic drug for cancer and muscular dystrophy, in human plasma and erythrocytes. "
08/01/1982 - "Ehrlich carcinoma was suppressed by treatment with 0.08 approximately 0.31 mg/kg/day of forphenicinol given for 10 days starting 5 days after tumor inoculation. "
04/01/1987 - "Clinical evaluation of forphenicinol, a low molecular weight immunomodulator, in patients with Mycobacterium avium, Mycobacterium intracellulare complex pulmonary infections has been conducted in a multicenter trial participated by 9 institutions in Kyushu during a period of 12 months from July 1982 to August 1983. "
04/01/1987 - "[Clinical trial of forphenicinol for the lung infection with Mycobacterium avium, Mycobacterium intracellulare complex]."
04/01/1987 - "Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms."
08/01/1982 - "Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections."
|2.||Amphotericin B (Amphotericin)
|8.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)